Crossmark

Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial

Crossref DOI link: https://doi.org/10.1016/j.ad.2024.08.010

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Melgosa-Ramos, F.J.

Vicente Villa, A.

Betlloch Mas, I.

Santos-Alarcón, S.
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2024-11-09
More Information

This article is maintained by: Elsevier

Article Title: Mid-term Safety and Efficacy of Upadacitinib in Adolescents With Moderate-to-severe Atopic Dermatitis: A Real-life 34-Patient Multicenter Trial

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2024.08.010

Content Type: simple-article

Copyright: © 2024 AEDV. Published by Elsevier España, S.L.U.